Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia

Clinical Colorectal Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles